
TRANS GENIC GROUP INC. — Investor Relations & Filings
TRANS GENIC GROUP INC. is a biotechnology company that operates through two main business segments: Drug Discovery Support and Investment & Consulting. The Drug Discovery Support division provides comprehensive services across the entire drug development pipeline, from basic research to non-clinical and clinical trials. Core services include the contract production of genetically modified animals, particularly mice, using genome editing technologies like CRISPR/Cas9. The company also specializes in contract antibody production, glycosylation analysis, and the supply of model mice. The Investment & Consulting segment focuses on M&A, business succession, and providing advisory and support services for business revitalization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 当社連結子会社による当社孫会社の吸収合併および連結子会社間の吸収合併に関するお知らせ | 2026-05-27 | Japanese | |
| 臨時報告書 | 2026-05-14 | Japanese | |
| 「エクソンヒト化マウス」に関する米国特許査定のお知らせ | 2026-04-22 | Japanese | |
| 確認書 | 2025-11-13 | Japanese | |
| 半期報告書-第28期(2025/04/01-2026/03/31) | 2025-11-13 | Japanese | |
| 訂正確認書 | 2025-08-01 | Japanese |
Browse filings by year
12 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
3 filings
| |||||
| 47251361 | 当社連結子会社による当社孫会社の吸収合併および連結子会社間の吸収合併に関するお知らせ | 2026-05-27 | Japanese | ||
| 45775927 | 臨時報告書 | 2026-05-14 | Japanese | ||
| 46878231 | 「エクソンヒト化マウス」に関する米国特許査定のお知らせ | 2026-04-22 | Japanese | ||
|
2025
11 filings
| |||||
| 8275048 | 確認書 | 2025-11-13 | Japanese | ||
| 8275033 | 半期報告書-第28期(2025/04/01-2026/03/31) | 2025-11-13 | Japanese | ||
| 7859628 | 訂正確認書 | 2025-08-01 | Japanese | ||
| 7859630 | 訂正有価証券報告書-第27期(2024/04/01-2025/03/31) | 2025-08-01 | Japanese | ||
| 7241592 | 訂正臨時報告書 | 2025-07-02 | Japanese | ||
| 7242344 | 臨時報告書 | 2025-07-01 | Japanese | ||
| 7244210 | 確認書 | 2025-06-30 | Japanese | ||
| 7244204 | 内部統制報告書-第27期(2024/04/01-2025/03/31) | 2025-06-30 | Japanese | ||
| 7244201 | 有価証券報告書-第27期(2024/04/01-2025/03/31) | 2025-06-30 | Japanese | ||
| 7259223 | 臨時報告書 | 2025-06-13 | Japanese | ||
| 7266406 | 臨時報告書 | 2025-04-23 | Japanese | ||
|
2024
1 filing
| |||||
| 7298253 | 確認書 | 2024-11-13 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alamar Biosciences, Inc.
Powering precision proteomics for earliest disease detectio…
|
ALMR | US | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
TRANS GENIC GROUP INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/13323/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=13323 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=13323 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=13323 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 13323}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TRANS GENIC GROUP INC. (id: 13323)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.